Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 1
1962 4
1963 3
1964 2
1965 1
1966 1
1967 1
1969 2
1970 2
1971 1
1972 4
1973 3
1974 5
1976 1
1977 1
1980 1
1981 2
1982 2
1983 5
1984 5
1985 2
1986 3
1987 4
1988 9
1989 12
1990 4
1991 9
1992 3
1993 7
1994 1
1995 4
1996 2
1997 4
1998 7
1999 14
2000 16
2001 13
2002 8
2003 4
2004 6
2005 8
2006 12
2007 17
2008 14
2009 21
2010 17
2011 19
2012 20
2013 16
2014 30
2015 34
2016 42
2017 44
2018 48
2019 33
2020 30
2021 28
2022 18
2023 16
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

572 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Connors JM, et al. Among authors: oki y. N Engl J Med. 2018 Jan 25;378(4):331-344. doi: 10.1056/NEJMoa1708984. Epub 2017 Dec 10. N Engl J Med. 2018. PMID: 29224502 Free PMC article. Clinical Trial.
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.
Westin J, Davis RE, Feng L, Hagemeister F, Steiner R, Lee HJ, Fayad L, Nastoupil L, Ahmed S, Rodriguez A, Fanale M, Samaniego F, Iyer SP, Nair R, Oki Y, Fowler N, Wang M, Ma MCJ, Vega F, McDonnell T, Pinnix C, Griffith D, Lu Y, Tewari S, Sun R, Scott DW, Flowers CR, Neelapu S, Green MR. Westin J, et al. Among authors: oki y. J Clin Oncol. 2023 Feb 1;41(4):745-755. doi: 10.1200/JCO.22.00597. Epub 2022 Aug 11. J Clin Oncol. 2023. PMID: 35952327 Free PMC article.
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.
Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, Izawa S, Ichijo T, Otsuki M, Omura M, Ogawa Y, Oki Y, Kurihara I, Kobayashi H, Sakamoto R, Satoh F, Takeda Y, Tanaka T, Tamura K, Tsuiki M, Hashimoto S, Hasegawa T, Yoshimoto T, Yoneda T, Yamamoto K, Rakugi H, Wada N, Saiki A, Ohno Y, Haze T. Naruse M, et al. Among authors: oki y. Endocr J. 2022 Apr 28;69(4):327-359. doi: 10.1507/endocrj.EJ21-0508. Epub 2022 Apr 12. Endocr J. 2022. PMID: 35418526 Free article.
NK-Cell Lymphomas.
Chihara D, Oki Y. Chihara D, et al. Among authors: oki y. Cancer Treat Res. 2019;176:163-184. doi: 10.1007/978-3-319-99716-2_8. Cancer Treat Res. 2019. PMID: 30596218
Decitabine--bedside to bench.
Oki Y, Aoki E, Issa JP. Oki Y, et al. Crit Rev Oncol Hematol. 2007 Feb;61(2):140-52. doi: 10.1016/j.critrevonc.2006.07.010. Epub 2006 Oct 4. Crit Rev Oncol Hematol. 2007. PMID: 17023173 Review.
Novel treatments for T-cell lymphoma.
Cheah CY, Oki Y, Fanale MA. Cheah CY, et al. Among authors: oki y. Am Soc Clin Oncol Educ Book. 2015:e468-78. doi: 10.14694/EdBook_AM.2015.35.e468. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993211 Free article. Review.
572 results